Retinal Blindness, Gene Therapy, CRISPR, and Artificial Intelligence | CheckRare.com
Kristin Smedley is the President of Curing Retinal Blindness Foundation, a non-profit organization focused on finding treatments and cures for CRB1 retinal disease.
Related Articles
ENPP1 and ABCC6 Deficiency Data Presented at ASBMR 2024
Kurt Gunter, MD, Inozyme Pharma, discusses data presented on ENPP1 deficiency and ABCC6 deficiency at ASBMR 2024.
Treatment Effect on Patient Pain and Quality of Life in Neuromyelitis Optica
Bruce Cree, MD, PhD, discusses a post hoc analysis of patient pain and quality of life data in treatment with Uplizna for NMO.
Patient Perspective: Challenges of Lipodystrophy
Andra Stratton, President and Co-founder of Lipodystrophy United, discusses the challenges of lipodystrophy from a patient’s perspective.
Results from Fabry Patient Survey
Lisa Berry, Genetic Counselor at Cincinnati Children’s Hospital, discusses results from Fabry patient survey.
Interim Data from the FORWARD-53 Trial for Duchenne Muscular Dystrophy
Paul Bolno and Anne-Marie Li-Kwai-Cheung of Wave Life Sciences, discuss interim data from the FORWARD-53 trial for DMD.
Analysis of Growth Hormone Replacement Therapy in Patients Under Age 60 Years
John Carmichael, MD, discusses an analysis of growth hormone replacement therapy in patients under the age of 60 years.
CTCL: Shortening the Diagnostic Journey and Starting Treatment Early
Yuliya Linhares, MD, Chief of Lymphoma Services at Miami Cancer Institute, discusses strategies for shortening the diagnostic journey of CTCL.
Results from a Phase 2 Trial of Pegcetacoplan in Patients With C3G and IC-MPGN
Fadi Fakhouri, MD, PhD, discusses the results from a phase 2 trial of pegcetacoplan in patients with C3G and IC-MPGN.
Erdheim-Chester Disease: Diagnosis and Treatment Options
Skand Shekhar, MD, Principal Investigator at the NIH, discusses Erdheim-Chester disease diagnosis and treatment options.